Optimizing Novel Heterobifunctional Degraders – An Update

By | 23 June 2026
  • Overview of Astellas’ TPD approach to overcome undruggable targets
  • Updating next-generation degrader candidates
  • Emerging DAC approaches to deliver TPD molecules to tumor tissues